CN102961435A - Medicinal composition for assisting to reduce blood sugar and preparation method thereof - Google Patents
Medicinal composition for assisting to reduce blood sugar and preparation method thereof Download PDFInfo
- Publication number
- CN102961435A CN102961435A CN2012104811514A CN201210481151A CN102961435A CN 102961435 A CN102961435 A CN 102961435A CN 2012104811514 A CN2012104811514 A CN 2012104811514A CN 201210481151 A CN201210481151 A CN 201210481151A CN 102961435 A CN102961435 A CN 102961435A
- Authority
- CN
- China
- Prior art keywords
- parts
- assisting
- blood sugar
- propolis
- medicinal composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a medicinal composition for assisting to reduce blood sugar and a preparation method thereof. The medicinal composition contains the following components in parts by weight: 29.5 parts of propolis, 30 parts of balsam pear, 25.5 parts of radix astragali and 10 parts of chromium picolinate. The medicinal composition is a granule taking medicinal and edible raw materials as the components. The medicinal composition disclosed by the invention is expected to achieve the effect of assisting to reduce blood sugar and is prepared through a scientific and reasonable production process by taking propolis, balsam pear, radix astragali and chromium picolinate as main raw materials; and the product is definite in function, controllable in quality and safe to take. The preparation method of the medicinal composition is simple, and the preparation process can be finished by conventional equipment.
Description
Technical field
The invention belongs to health product technology field, relate to a kind of pharmaceutical composition of health product, particularly a kind of pharmaceutical composition for assisting in reducing blood sugar and preparation method thereof.
Background technology
The expection of developing drugs combination product reaches the health care of assisting in reducing blood sugar.This product adopts scientific and reasonable production technology to process take propolis, Fructus Momordicae charantiae, the Radix Astragali, chromium picolinate as primary raw material, and this product function is clear and definite, and is quality controllable, takes safety.
Diabetes are absolute because of insulin or relative deficiency causes a kind of disease of carbohydrate metabolism disturbance in the body, its clinical whole body chronic metabolic disease take hyperglycemia, hyperlipidemia, high blood viscosity tendency as outstanding feature.The onset diabetes rate is higher at present.The harm of diabetes not only is its disease itself, more is various acute and chronic complication, as can not get in time appropriate prophylactic treatment, usually because of multiple complications disable deadly, existing quality of life of seriously having jeopardized people.
Summary of the invention
Purpose of the present invention aims to provide a kind of pharmaceutical composition for assisting in reducing blood sugar and preparation method thereof, this pharmaceutical composition is a kind of take the integration of edible and medicinal herbs raw material as main health product, this product is take propolis, Fructus Momordicae charantiae, the Radix Astragali as main component, be aided with chromium picolinate, four kinds of composition synergism accelerate the islets of langerhans blood circulation, improve pancreas and produce insulin, reach the health care of assisting in reducing blood sugar, take the crowd and can not produce dependency.
Technical scheme of the present invention is: design a kind of pharmaceutical composition for assisting in reducing blood sugar, it is characterized in that composition and weight proportion thereof that it contains are: 29.5 parts of propolis, 30 parts in Fructus Momordicae charantiae, 25.5 parts of the Radixs Astragali, 10 parts of chromium picolinates.
The preparation method of described a kind of pharmaceutical composition for assisting in reducing blood sugar is characterized in that it may further comprise the steps:
1) takes by weighing raw material by following weight ratio: 29.5 parts of propolis, 30 parts in Fructus Momordicae charantiae, 25.5 parts of the Radixs Astragali, 10 parts of chromium picolinates;
2) with above propolis, Fructus Momordicae charantiae, the Radix Astragali, decoct with water secondary, 2 hours for the first time, 1.5 hours for the second time, gradation filtered, and merging filtrate dusts with spray dryer, and is for subsequent use;
3) dry powder described in the step 2 is mixed with chromium picolinate, evenly, for subsequent use;
4) dry powder described in the step 3 is added 5 parts of starch, 10 parts of anhydrous glucose, 10 parts of steviosides, mix homogeneously;
5) said mixture is added 80% ethanol soft material processed;
6) granulate arrangement with soft material 14 mesh sieves;
7) packing, warehouse-in get final product.
Advantage of the present invention is: the monarch drug propolis have the title of " purple gold " among the present invention, has islet cells and the functions such as tissue, blood sugar lowering of activating cell, promotion tissue regeneration, reparation disease damage.Silymarin in the propolis can be removed free radical, stabilate film, and islets of langerhans damage is shielded, and propolis can also strengthening immune system, strengthens the immunocyte vigor; Fructus Momordicae charantiae can blood sugar lowering, blood fat reducing, raising immunity, endocrine regulation, antioxidation, antitumor etc.Sugar-lowering components is mainly Saponin and vegetable protein in the Fructus Momordicae charantiae, and it is low obviously to improve carbohydrate tolerance, and fasting hypoglycemia is had again certain preventive effect.The Radix Astragali can reduce the high blood coagulation of diabetes, high glutinous state, thrombosis in dissolving or the prevention glomerule blood capillary, improve to a certain extent the high intrinsic pressure and high filtration of kidney, thereby reduce the drainage of albumen, effectively delay or stop the end stagerenaldisease that develops into of diabetes.Chromium in the chromium picolinate is the necessary trace element of humans and animals, it is the important composition composition that consists of glucose tolerance factor (G ball), participated in sugar and the dim boat metabolism of body as the Booster of insulin action, physiological regulation and growth promoter have all been had considerable influence.
This prescription not only can blood sugar lowering, can also enhancing immunity, other diseases there is auxiliary therapeutic action.It is theoretical that pharmaceutical composition of the present invention is used Traditional health care, take propolis, Fructus Momordicae charantiae, the Radix Astragali as main component, is aided with chromium picolinate, four kinds of composition synergism, accelerate the islets of langerhans blood circulation, improve pancreas islet gland and produce insulin, reach the health care of assisting in reducing blood sugar.No dependence, safety, effectively.
The specific embodiment
The invention will be further described below in conjunction with specific embodiment, but not as limitation of the present invention.The part that is not described in detail in the present embodiment is to adopt prior art, and industry standard or known approaches.
Embodiment 1
Described pharmaceutical composition provided by the invention adopts following steps to make:
1) takes by weighing raw material by following weight ratio: 29.5 parts of propolis, 30 parts in Fructus Momordicae charantiae, 25.5 parts of the Radixs Astragali, 10 parts of chromium picolinates;
2) with above propolis, Fructus Momordicae charantiae, the Radix Astragali, decoct with water secondary, 2 hours for the first time, 1.5 hours for the second time, gradation filtered, and merging filtrate dusts with spray dryer, and is for subsequent use;
3) dry powder described in the step 2 is mixed with chromium picolinate, evenly, for subsequent use;
4) dry powder described in the step 3 is added 5 parts of starch, 10 parts of anhydrous glucose, 10 parts of steviosides, mix homogeneously;
5) said mixture is added 80% ethanol soft material processed;
6) granulate arrangement with soft material 14 mesh sieves;
7) packing, warehouse-in get final product.
The embodiment of the invention 1 is used for the clinical observation of the medicine composite for curing hyperglycemia of assisting in reducing blood sugar
1 data and method
1.1 physical data
Select diabetics 100 examples receive treatment voluntarily, male 40 examples, women 60 examples, age 25-65 year.Be divided at random treatment group 1, treatment group 2, each 25 example for the treatment of group 3 and matched group, each organizes patient age symptom formation without significant difference, and disease time is the longest 6 years, the shortest March.Has comparability (P〉0.05).
1.2 Therapeutic Method
The treatment group Primary Care is consistent, and matched group is not taken medicine.The treatment group 1 usefulness embodiment of the invention 1, every day three times, one time 1 bag, 30 is a course for the treatment of.Treatment group 2 usefulness SHENQI JIANGTANG sheets (outsourcing is produced by Shantou pharmaceutical factory, and each 5,3 times on the 1st.The glibenclamide for the treatment of group 3 usefulness Fengxin full brightness Pharmaceutical Technology Co., Ltd, each a slice, one day three times.
2 results
2.1 curative effect determinate standard
Produce effects: tcm clinical practice symptom, sign are obviously improved, and fasting glucose and 2h-plasma glucose drop to normal range; Effectively: tcm clinical practice symptom, sign all take a favorable turn, and fasting glucose and 2h-plasma glucose descend above 20% before the treatment; Invalid: fasting glucose and 2h-plasma glucose descend not obvious, or symptom is without improvement.
2.2 therapeutic outcome
| ? | Produce effects | Take a turn for the better | Invalid | Effective percentage |
| Matched group | 0 | 0 | 25 | 0% |
| Treatment group 1 | 10 | 13 | 2 | 92% |
| Treatment group 2 | 7 | 13 | 5 | 80% |
| Treatment group 3 | 8 | 14 | 3 | 88% |
3 discuss
Differential diagnosis in tcm is learned and is thought that the multifactor body natural endowment of diabetes is weak, the plain body deficiency of YIN, disorder of emotion, depression of liver-QI.Because long-term feelings will is not relaxed, stasis is given birth to heat, injuring YIN due to production of dryness; Or because of rage, cause liver to lose bar and reach; Mechanism of qi retardance, it is dry also can to give birth to transconversion into heat, and cloudy Tianjin of the bright lung stomach that can disappear, causes lung dryness of the stomach heat, and thirsty polydipsia occurs, rapid digestion of food and polyorexia.With the passing of time the deficiency of YIN scorching, must cause deficiency of both QI and YIN.Deficiency of YIN affecting YANG and the deficiency of QI and declination of YANG phenomenon occurs, because lung, stomach, kidney three be through the cloudy deficiency of vital energy, the deficiency of both YIN and YANG disease that yang-energy is held back and occurred.Adopt the present invention to make up and to realize depressed liver-energy dispersing and QI regulating, yin nourishing nourishing kidney, clearing heat and relieving fidgetness, the effect of blood sugar lowering with the balance the body function.Can accelerate the islets of langerhans blood circulation, improve pancreas and produce insulin.And then reach the treatment various diabetes effect.And then illustrate that embodiment 1 affiliated prescription is reliably effective in this invention.
Claims (2)
1. a pharmaceutical composition that is used for assisting in reducing blood sugar is characterized in that composition and weight proportion thereof that it contains are 29.5 parts of propolis, 30 parts in Fructus Momordicae charantiae, 25.5 parts of the Radixs Astragali, 10 parts of chromium picolinates.
2. the preparation method of a kind of pharmaceutical composition for assisting in reducing blood sugar according to claim 1, it may further comprise the steps
1) takes by weighing raw material by following weight ratio: 29.5 parts of propolis, 30 parts in Fructus Momordicae charantiae, 25.5 parts of the Radixs Astragali, 10 parts of chromium picolinates;
2) with above propolis, Fructus Momordicae charantiae, the Radix Astragali, decoct with water secondary, 2 hours for the first time, 1.5 hours for the second time, gradation filtered, and merging filtrate dusts with spray dryer, and is for subsequent use;
3) dry powder described in the step 2 is mixed with chromium picolinate, evenly, for subsequent use;
4) dry powder described in the step 3 is added 5 parts of starch, 10 parts of anhydrous glucose, 10 parts of steviosides, mix homogeneously;
5) said mixture is added 80% ethanol soft material processed;
6) granulate arrangement with soft material 14 mesh sieves.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104811514A CN102961435A (en) | 2012-11-23 | 2012-11-23 | Medicinal composition for assisting to reduce blood sugar and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104811514A CN102961435A (en) | 2012-11-23 | 2012-11-23 | Medicinal composition for assisting to reduce blood sugar and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102961435A true CN102961435A (en) | 2013-03-13 |
Family
ID=47792054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012104811514A Withdrawn CN102961435A (en) | 2012-11-23 | 2012-11-23 | Medicinal composition for assisting to reduce blood sugar and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102961435A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111387502A (en) * | 2020-05-15 | 2020-07-10 | 西安皇家医疗保健品有限公司 | Propolis-bitter gourd composition with auxiliary blood sugar reducing effect and preparation method thereof |
| CN113244295A (en) * | 2021-06-03 | 2021-08-13 | 绵阳德康疼痛医院 | A Chinese medicinal capsule for treating diabetes, and its preparation method and application method |
| CN114392296A (en) * | 2022-01-21 | 2022-04-26 | 长春工业大学 | Purslane composite sugar control tablet and preparation method thereof |
-
2012
- 2012-11-23 CN CN2012104811514A patent/CN102961435A/en not_active Withdrawn
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111387502A (en) * | 2020-05-15 | 2020-07-10 | 西安皇家医疗保健品有限公司 | Propolis-bitter gourd composition with auxiliary blood sugar reducing effect and preparation method thereof |
| CN113244295A (en) * | 2021-06-03 | 2021-08-13 | 绵阳德康疼痛医院 | A Chinese medicinal capsule for treating diabetes, and its preparation method and application method |
| CN114392296A (en) * | 2022-01-21 | 2022-04-26 | 长春工业大学 | Purslane composite sugar control tablet and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102648752B (en) | Engineering rice suitable for people having unbalanced diet and with function of reducing blood glucose and preparation method of engineering rice | |
| CN102526478B (en) | Formula of health-care medicine with functions of strengthening immunity and reducing blood sugar | |
| CN105105116A (en) | Health food with effects of relieving physical fatigue and enhancing immunity and preparation method of health food | |
| CN102172385A (en) | Chinese medicinal preparation with effects of enhancing immunity, lowering blood sugar and lowering blood fat | |
| CN103431392A (en) | Composite marine food for special dietary uses for diabetics | |
| CN105707637A (en) | Solid beverage capable of reduce blood glucose, and preparation method thereof | |
| CN102113534B (en) | Moon cake with function of treating diabetes and preparation method thereof | |
| CN103494190B (en) | Preparation method for polyghace-seche ginseng softgel | |
| CN102961435A (en) | Medicinal composition for assisting to reduce blood sugar and preparation method thereof | |
| CN109043553A (en) | A kind of Special food and preparation method thereof that patients with gestational diabetes is edible | |
| CN102150844B (en) | Dried noodles with function of treating diabetes and preparation method of dried noodles | |
| CN103989996B (en) | It is a kind of to treat Chinese medicine composition of diabetes and preparation method thereof | |
| CN102178718B (en) | Preparation used for treating diabetes mellitus and preventively treating heart cerebrovascular disease | |
| CN109043555A (en) | A kind of Special food and preparation method thereof that hyperglycemic patients are edible | |
| CN109771578A (en) | The composition for preventing and treating diabetes and complication | |
| CN103622027A (en) | Health-care food composition for reducing blood glucose | |
| CN106036384A (en) | Health preservation porridge suitable for diabetes patients to eat and making method of health preservation porridge | |
| CN102949459A (en) | Medicinal composition for reducing blood sugar and capsule preparation method of the medicinal composition | |
| CN110507707A (en) | A kind of Chinese medicine composition and preparation method thereof for treating type II diabetes | |
| CN109498788A (en) | It is a kind of to treat turbid tune sugar-pill of drop that diabetes B stagnation of turbid phlegm in middle-JIAO is demonstrate,proved and middle and preparation method thereof | |
| CN104740345B (en) | Treat Chinese medicine composition of diabetes and preparation method thereof | |
| CN101822698A (en) | Method for preparing black fungus and pantotrichum hypoglycemic composition | |
| Yin et al. | Hypoglycaemic effect of coixan from Coix seeds on mice | |
| CN1850251A (en) | Medicine for treating nephrosis syndrome | |
| CN112402555A (en) | Composition for preventing and treating sub-health and diabetes and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C04 | Withdrawal of patent application after publication (patent law 2001) | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20130313 |